UnitedHealth Group (NYSE:UNH) Releases Quarterly Earnings Results, Beats Estimates By $0.55 EPS

Key Points

• UnitedHealth beat earnings expectations: Third-quarter adjusted EPS reached $4.69, exceeding the $4.14 consensus estimate and rising sharply from $2.59 a year earlier.
• Full-year outlook was raised: The company now expects 2026 earnings of approximately $19.50–$20.00 per share, supported by improved medical-cost management, value-based care and AI investments.
• Growth remains mixed: Optum Health revenue declined, creating a potential constraint despite stronger margins and profitability. Analysts maintain a “Moderate Buy” consensus, with an average price target of $462.59.

UnitedHealth Group (NYSE:UNH - Get Free Report) issued its quarterly earnings results on Tuesday. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts' consensus estimates of $4.14 by $0.55, reports. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%. During the same period in the prior year, the company earned $2.59 earnings per share.

UnitedHealth Group Price Performance

Shares of UNH opened at $377.98 on Tuesday. UnitedHealth Group has a 52 week low of $255.96 and a 52 week high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a market cap of $339.27 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 1.43 and a beta of 0.60. The stock has a 50 day moving average of $388.03 and a 200-day moving average of $381.81.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a $2.32 dividend. The ex-dividend date was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is presently 59.72%.

Insider Activity

In related news, CEO Patrick Conway sold 1,169 shares of the firm's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.19% of the company's stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted third-quarter earnings of $4.69 per share, ahead of the $4.12 analyst consensus and up from $2.92 a year earlier. Reported net income was $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the prior-year quarter. UnitedHealth Group Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: The company raised its full-year 2026 earnings outlook to approximately $19.50-$20.00 per share, signaling greater confidence in profitability and supporting the stock’s rally. UnitedHealth Group tops estimates and hikes profit outlook
• Positive Sentiment: Medical-cost management showed improvement, a key issue for health insurers. UnitedHealth also cited progress from value-based care and artificial-intelligence investments, suggesting potential support for longer-term margins and efficiency. UnitedHealth Earnings Beat Wall Street Estimates
• Neutral Sentiment: Optum Health revenue declined, creating a potential constraint on overall growth even as the company delivered better earnings and raised guidance. Investors are likely to watch whether improved margins can offset weaker top-line performance. UnitedHealth raises guidance as Optum Health revenue slips

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on UNH shares. Erste Group Bank lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Thursday, August 27th. BMO Capital Markets set a $512.00 price target on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Truist Financial lifted their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. Piper Sandler increased their price objective on shares of UnitedHealth Group from $477.00 to $499.00 and gave the company an "overweight" rating in a research note on Friday, July 17th. Finally, Barclays raised their price objective on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an "overweight" rating in a report on Monday, July 20th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $462.59.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.